Prawo i regulacje · 30/09/2025

U.S. Federal Trade Commission Approves Pfizer's Acquisition of BioNTech, Following Review of Proposed Transaction

The U.S. Federal Trade Commission has approved Pfizer's acquisition of BioNTech, following a review of the proposed transaction, which is expected to close in the first half of 2024, subject to customary closing conditions